AstraZeneca PLC (AZN)
NYSE
$166.58+$2.02 (+1.23%) on the dayAs of the close; data may be delayed.
AZN price, last 12 months
Key stats
- Previous close
- $164.56
- Open
- $166.16
- Day range
- $164.60 – $166.81
- 52-week range
- $145.79 – $212.71
- Volume
- 2.1M
- Avg volume (20 days)
- 3.1M
- Market cap
- $258.3B
Performance
1W+0.3%
1M+0.2%
3M−11.6%
6M−9.2%
YTD−9.4%
1Y+10.5%
vs S&P 500, 1Y−6.3 pts
Technicals and fundamentals
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
- Listed on
- NYSE
- Market cap
- $258.3B